• Western blot analysis of PC-3 cells using Phospho-PPAR-Gamma (S112) Polyclonal Antibody diluted at 1:500
  • Western blot analysis of lysates from Jurkat cells treated with Paclitaxel 1uM 24h, using PPAR-gamma (Phospho-Ser112) Antibody. The lane on the right is blocked with the phospho peptide.
  • Western blot analysis of various cells using Phospho-PPAR-Gamma (S112) Polyclonal Antibody diluted at 1:500

Anti-Phospho-PPARG-Ser112 antibody (78-127 aa) (STJ90476)

SKU:
STJ90476

Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Phospho-Peroxisome proliferator-activated receptor gamma-Ser112 (78-127 aa) is suitable for use in Western Blot and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
ELISA 1:10000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: PPARG
Gene ID: 5468
Uniprot ID: PPARG_HUMAN
Immunogen Region: 78-127 aa
Specificity: Phospho-PPAR-Gamma (S112) Polyclonal Antibody detects endogenous levels of PPAR-Gamma protein only when phosphorylated at S112.
Immunogen: The antiserum was produced against synthesized peptide derived from the human PPAR-gamma around the phosphorylation site of Ser112 at the amino acid range 78-127
Post Translational Modifications O-GlcNAcylation at Thr-84 reduces transcriptional activity in adipocytes. Phosphorylated in basal conditions and dephosphorylated when treated with the ligand. May be dephosphorylated by PPP5C. The phosphorylated form may be inactive and dephosphorylation at Ser-112 induces adipogenic activity. Ubiquitinated by E3 ubiquitin-protein ligase complex containing FBXO9.leading to proteasomal degradation.
Function Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated pro-inflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of BMAL1 in the blood vessels. (Microbial infection) Upon treatment with M.tuberculosis or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production are modulated, probably via this protein.
Protein Name Peroxisome Proliferator-Activated Receptor Gamma
Ppar-Gamma
Nuclear Receptor Subfamily 1 Group C Member 3
Database Links Reactome: R-HSA-1989781
Reactome: R-HSA-381340
Reactome: R-HSA-383280
Reactome: R-HSA-4090294
Reactome: R-HSA-8943724
Reactome: R-HSA-9022707
Cellular Localisation Nucleus
Cytoplasm
Redistributed From The Nucleus To The Cytosol Through A Map2k1/Mek1-Dependent Manner
Noct Enhances Its Nuclear Translocation
Alternative Antibody Names Anti-Peroxisome Proliferator-Activated Receptor Gamma antibody
Anti-Ppar-Gamma antibody
Anti-Nuclear Receptor Subfamily 1 Group C Member 3 antibody
Anti-PPARG antibody
Anti-NR1C3 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance